BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21086492)

  • 1. Pushing the limits forward: transradial superficial femoral artery stenting.
    Trani C; Tommasino A; Burzotta F
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1065-71. PubMed ID: 21086492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transradial approach to treat superficial femoral artery in-stent restenosis.
    Trani C; Burzotta F; Tommasino A; Giammarinaro M
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):494-8. PubMed ID: 19434751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What I could do with just a few more inches: lament of a radialist.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1072. PubMed ID: 21108380
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined Radial-Pedal Access Strategy and Radial-Pedal Rendezvous in the Revascularization of Complex Total Occlusions of the Superficial Femoral Artery (the "No Femoral Access" Strategy).
    Hanna EB; Prout DL
    J Endovasc Ther; 2016 Apr; 23(2):321-9. PubMed ID: 26848132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radial access for peripheral transluminal angioplasty.
    Coscas R; de Blic R; Capdevila C; Javerliat I; Goëau-Brissonniere O; Coggia M
    J Vasc Surg; 2015 Feb; 61(2):463-8. PubMed ID: 25135875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular Therapy of the Superficial Femoral Artery Via a Stand-Alone Transradial Access: A Single-Center Experience.
    Hanna EB; Ababneh BA; Amin AN
    Vasc Endovascular Surg; 2018 Feb; 52(2):107-114. PubMed ID: 29179651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New stents for SFA.
    MINAR E; SCHILLINGER M
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):635-45. PubMed ID: 19741579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary nitinol stenting for femoropopliteal disease.
    Mewissen MW
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial results of transradial iliac artery stenting.
    Shinozaki N; Ogata N; Ikari Y
    Vasc Endovascular Surg; 2014 Jan; 48(1):51-4. PubMed ID: 24203346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating the diseased superficial femoral artery.
    Gibbs JM; Peña CS; Benenati JF
    Tech Vasc Interv Radiol; 2010 Mar; 13(1):37-42. PubMed ID: 20123431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Length matters: outcomes of superficial femoral artery (SFA) endovascular interventions.
    Hillegass WB
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1096. PubMed ID: 19953522
    [No Abstract]   [Full Text] [Related]  

  • 15. Retrograde stent-graft angioplasty of superficial femoral artery occlusion in a claudicant.
    Lesperance RN; Singh NN; Curry TK; Andersen CA
    Vasc Endovascular Surg; 2009; 43(1):83-6. PubMed ID: 18829584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transradial intervention of iliac and superficial femoral artery disease is feasible.
    Sanghvi K; Kurian D; Coppola J
    J Interv Cardiol; 2008 Oct; 21(5):385-7. PubMed ID: 18705637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions.
    Ko YG; Kim JS; Choi DH; Jang Y; Shim WH
    J Endovasc Ther; 2007 Jun; 14(3):374-81. PubMed ID: 17723006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transradial bilateral iliac stenting.
    Staniloae CS; Kurian DC; Coppola JT
    J Invasive Cardiol; 2006 Oct; 18(10):E256-7. PubMed ID: 17015919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.